跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AXOTIDE CFC-Free fluticasone propionate 250 microgram/dose inhalation metered dose aerosol can - TGA Drug Approval Details
Approvals
/
TGA
/
AXOTIDE CFC-Free fluticasone propionate 250 microgram/dose inhalation metered dose aerosol can
Approved
STANDARD
AXOTIDE CFC-Free fluticasone propionate 250 microgram/dose inhalation metered dose aerosol can
GlaxoSmithKline Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
11b2ca13c02c080b
Company
GlaxoSmithKline Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
11b2ca13c02c080b
Product Name
AXOTIDE CFC-Free fluticasone propionate 250 microgram/dose inhalation metered dose aerosol can
Artg Id
267495
Artg Name
AXOTIDE CFC-Free fluticasone propionate 250 microgram/dose inhalation metered dose aerosol can
Sponsor
GlaxoSmithKline Australia Pty Ltd
Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd
Artg Date
2016-03-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/10f2bffc0ad96e69d722a8670d0479c9.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/0267a03eaf420121aa36135929c8c931.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
11b2ca13c02c080b
Type
Standard
Back to TGA Approvals